-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.O2.6 723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence II

Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, adult, Translational Research, epidemiology, Clinical Research, Combination therapy, Diseases, patient-reported outcomes, Therapies, survivorship, Study Population, Human, Transplantation, Vaccines
Saturday, December 10, 2022: 4:00 PM-5:30 PM
353-355 (Ernest N. Morial Convention Center)
Moderators:
Richard J. Lin, MD, Memorial Sloan Kettering Cancer Center and Gregory M Guilcher, MD, BSc, FRCPC, Section of Pediatric Hematology, Oncology and BMT, University of Calgary, Alberta Children’s Hospital
Disclosures:
Lin: Kite, A Gilead Company: Consultancy; Magenta Therapeutics: Consultancy. Guilcher: Bluebirdbio: Other: PI of Project Sickle Cure, a Sickle Cell Transplant Advocacy and Research Alliance study partially funded by bluebirdbio, Research Funding; Bristol Myers Squibb: Other: I serve on a steering committee for a clinical trial for which BMS provides funding., Research Funding.
4:00 PM

Maryam Rafati, MD, PhD1*, Derek W Brown1*, Weiyin Zhou1*, Kristine Jones1,2*, Wen Luo3,4*, Andrew St. Martin, MS5*, Youjin Wang, PhD, BPharm1*, Stephen R. Spellman6*, Tao Wang, PhD5,7*, H. Joachim Deeg, MD8, Vikas Gupta, MD, FRCP, FRCPath9, Stephanie J. Lee, MD, MPH10,11, Stephen J. Chanock, MD1*, Mitchell Machiela, PhD1*, Wael Saber, MD, MS5 and Shahinaz M. Gadalla, MD, PhD12

1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
2Cancer Genomics Research Laboratory, Frederick National Laboratory, Frederick, MD
3Division of Cancer Epidemiology and Genetics,, National Cancer Institute, Rockville, MD
4Frederick National Laboratory for Cancer Research, Frederick, MD
5CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
7Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
10CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match®, Medical College of Wisconsin, Milwaukee, WI
11Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
12Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD

4:15 PM

Muhammad Bilal Abid, MD, MS, MRCP, FRCP1*, Noel Estrada-Merly, MS1*, Mei-Jie Zhang, PhD1,2*, Karen Chen, MS1*, David S. Allan, MD, FRCPC, MSc3, Christopher Bredeson, MD, MSc, FRCPC3*, Mitchell Sabloff, MSc, MD, FRCPC3, Mark R. Litzow, MD4, Partow Kebriaei, MD5 and Wael Saber, MD, MS1

1CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
4Mayo Clinic, Rochester, MN
5Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

4:30 PM

Mallory Taylor, MD1*, Steve W. Cole, PhD2*, Joelle Strom, MS3*, Ruta Brazauskas, PhD4*, K. Scott Baker, MD, MS5, Rachel Phelan, MD, MPH6,7, David K. Buchbinder, MD, MSHS8, Betty K. Hamilton, MD9, Helene Schoemans, MD10* and Jennifer M Knight, MD MS11,12,13*

1Palliative Care and Resilience Program, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA
2Departments of Psychiatry & Biobehavioral Sciences and Medicine, UCLA School of Medicine, Los Angeles, CA
3CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Division of Biostatistics. Institute for Heath and Equity, Medical College of Wisconsin, Milwaukee, WI
5Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
6Division of Hematology and Oncology- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
7CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
8Department of Hematology, Children's Hospital of Orange County, Orange, CA
9Cleveland Clinic Foundation, Cleveland, OH
10Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, Leuven, Belgium
11Department of Psychiatry and Departments of Medicine and Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI
12Section of BMT & Cellular Therapies; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
13Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI

4:45 PM

Ghayas C. Issa, MD1, Branko Cuglievan, MD2*, Eytan Stein, MD3, Martha L. Arellano, MD4, Andrius Zucenka, MD5*, Nandita Khera, MD, MPH6, Richard M. Stone, MD7, Michael J. Thirman, MD8, John F. DiPersio, MD, PhD9, Nicole Karras, MD10*, Yu Gu, PhD11*, Rebecca G. Bagley, MA11*, Galit Rosen, MD11, David Tamang11*, Kimberly Dishman, NP11*, Sushama Scalera, MD11*, Michael L. Meyers, MD, PhD11*, Kate Madigan, MD11*, Nicole McNeer, MD, PhD11 and Ibrahim Aldoss, MD12

1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
5Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
6Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
7Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
9Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
10Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
11Syndax Pharmaceuticals, Inc., Waltham, MA
12City of Hope, Duarte, CA

5:00 PM

Jacqueline S. Garcia, MD1, Haesook T Kim, PhD1, Jennifer Brock2*, H. Moses Murdock, MD2, Corey S. Cutler, MD, MPH, FRCPC3*, Daniel J. DeAngelo, MD, PhD2*, Christopher J. Gibson, MD1, Mahasweta Gooptu, MD2, Vincent Ho, MD4*, John Koreth, MBBS, DPhil5, Marlise R. Luskin, MD1, Sarah Nikiforow, MD, PhD1*, Rizwan Romee, MD6, Roman M Shapiro, MD7, Richard M. Stone, MD8, Martha Wadleigh, MD9*, Eric S. Winer, MD1, Michela Ansuinelli4*, Eliza Elliot4*, Geoffrey Fell4*, Hannah Karp4*, Jeremy Ryan1*, Anthony G. Letai, MD, PhD1, Coleman Lindsley, MD, PhD1, Robert J Soiffer, MD10, Joseph H. Antin, MD11, Fiona Loschi4* and Jerome Ritz, MD, PhD5

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Boston
5Dana-Farber Cancer Institute, Division of Hematologic Malignancies and Harvard Medical School, Boston, MA
6Dana Farber Cancer Institute, Boston, MA
7Department of Medical Oncology, Dana-Farber Cancer Institute, Jamaica Plain, MA
8Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
10Division of Stem Cell Transplant and Cellular Therapies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

5:15 PM

Emily C. Liang, MD1,2, Lynn E. Onstad, ScM1*, Paul A. Carpenter, MD1,3, Steven A. Pergam, MD, MPH1,2,4*, Stephanie J. Lee, MD, MPH1,2 and Catherine Liu, MD1,2,4*

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA
3Department of Pediatrics, University of Washington, Seattle, WA
4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA

*signifies non-member of ASH